IARS1 and breast neoplasm: Using median expression values, IRS gene signatures were significantly enriched according to molecular breast tumor subtype (basal-like, claudin-low, HER2-enriched, luminal A, luminal B, and normal-like) in the UNC337 (GSE18229) cohort (Fig 2C) [15, 16].